|drug1962||Mask without Mask Adhesive / Arm 2 Wiki||1.00|
There is one clinical trial.
To reduce interface leak and aerosol spread, Philips has developed an accessory to non-invasive ventilation(NIV) masks to be used with the Philips AF531 and the PerformaTrak mask on respiratory failure patients. For the purposes of capturing initial mask leak and safety data, this trial will enroll patients treated with NIV in an institutional setting (i.e., sleep lab).
Description: Proportion of patients who have severe and extreme skin irritation that persists for ≥ 30 min after mask adhesive removal (score of ≥ 3 on a 5-point grading system). Clinician-perceived mask adhesive ease of use as measured by a 0-10 Likert Scale with 0 being extremely difficult and 10 being extremely easy (initial impressions/end of study).Measure: Medical Adhesive-Related Skin Injury (MARSI) and Ease of Use Time: 30 days
Description: Calculated percentage change in leak volume (L/min) after mask adhesive use as compared to the use of the mask without the adhesive.Measure: Leak Change Time: 30 days
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports